PhD candidates
Current:
Henrik Horndalsveen
Durvalumab after chemoradiation for stage III non-small lung cancer patients – the DART study
Supervisors: Åslaug Helland (main), Vilde Drageset Haakensen (co), Maria Moksnes Bjaanæs (co)
Saima Farooqi
Circulating cytokines in patients treated with double immunotherapy with our without UV1 vaccination – relation to side effects and clinical benefit
Supervisors: Vilde Drageset Haakensen (main), Åslaug Helland (co), Åsa Öjlert (co), Maria Moksnes Bjaanæs (co)
Hanne Marte Gjertsen Nymoen
Thoracic radiotherapy combined with systemic treatment for patients with non-small cell lung cancer – clinical effect and gut microbiome biomarkers
Supervisors: Vilde Drageset Haakensen (main), Åslaug Helland (co), Tine Alver (co), Maria Moksnes Bjaanæs (co)
Solfrid Thunold
PET-features as biomarkers for immune response and clinical effect for patients with pleural mesothelioma treated with ipilimumab and nivolumab with or without UV1 vaccine
Supervisors: Vilde Drageset Haakensen (main), Eirik Malinen (co), Eivor Hernes (co), Åslaug Helland (co)
Alumni:
Maria Moksnes Bjaanæs (2016)
Molecular characterization of non-small cell lung cancer tumors
Supervisors: Åslaug Helland (main), Odd Terje Brustugun (co)
Camilla Sagerup (2016)
Epidemiological and molecular characteristics of lung cancer. Population-based and molecular studies.
Supervisors: Odd Terje Brustugun (main), Åslaug Helland (co)
Ann Rita Halvorsen (2017)
Circulating microRNAs; biomarkers for early detection, prediction of therapy response and prognosis in cancer patients.
Supervisors: Åslaug Helland (main), Vilde Drageset Haakensen (co)
Marc Kevin McGowan (2019)
Drug-Resistance and Protective Factors in NSCLC
Supervisors: Odd Terje Brustugun (main), Åslaug Helland (co)
Hanne Eide (2020)
Serum and tumour biomarkers in non-small cell lung cancer
Supervisors: Åslaug Helland (main)
Åsa Öjlert (2021)
The non-small cell lung cancer tumor immune microenvironment: implications for treatment and prognosis
Supervisors: Åslaug Helland (main)
Inger Johanne Zwicky Eide (2023)
Novel EGFR-directed therapy – a clinical study
Supervisors: Odd Terje Brustugun (main), Åslaug Helland (co)
Janna Berg (2023)
Pulmonary function and serum biomarkers in patients with non-small cell lung cancer, radiation pneumonitis and chronic obstructive lung disease
Supervisors: Åslaug Helland (main)